HiFiViral Solution Helps to Accelerate Understanding of the Omicron Variant, Providing Information that is Important to Public Health Response MENLO PARK, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) — PacBio (Nasdaq:…
Collaboration Aims to Identify Variants Not Easily Detectible by Short-Read Sequencing, Increasing Diagnostic Yield in Rare Disease Patients MENLO PARK, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) — PacBio (Nasdaq: PACB),…
MENLO PARK, Calif., Dec. 03, 2021 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s…
Strategic Hire Will Expand Company’s Commercial Presence in Key Geography MENLO PARK, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) — PacBio (NASDAQ:PACB), a leading provider of high-quality, long-read sequencing platforms, welcomes…
MENLO PARK, Calif., Nov. 19, 2021 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s…
Whole Genome HiFi Sequencing Will Be Used on Unexplained Rare Disease Cases to Evaluate If It Can Identify Variants Not Readily Detectable by Short-Read Sequencing MENLO PARK, Calif., Nov. 18,…
Robust SARS-CoV-2 Sequencing Kit and Upgraded Microbial Whole Genome Assembly Workflow Enable Public Health Laboratories to Scale Pathogen Surveillance Programs MENLO PARK, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) — PacBio…
MENLO PARK, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) — PacBio announced today that its executives will be speaking at the following investor conferences: Stifel 2021 Virtual Healthcare Conference on November…
MENLO PARK, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2021. Record revenue reflects 6th straight quarter of…
Leading Global Genomics and Diagnostic Testing Firm Adds More Comprehensive Genetic Information to its Services MENLO PARK, Calif. and HONG KONG, Nov. 02, 2021 (GLOBE NEWSWIRE) — PacBio will be…
MENLO PARK, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its third quarter 2021 financial results…
Partnership to Improve Biodiversity Research, Accelerate Conservation with Actionable and Accurate Genomic Data MENLO PARK, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences”…
MENLO PARK, Calif., Sept. 24, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing platforms, today announced…
Omniome’s High Accuracy Short-Read Sequencing Platform Expected to Significantly Expand PacBio’s Market Opportunity. Acquisition Expected to Accelerate the Adoption of SMRT Sequencing, PacBio’s Leading Long-Read Sequencing Platform. PacBio Also Closes…
MENLO PARK, Calif., Sept. 03, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences: Wells…
If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.